Hester Biosciences has informed that a meeting of the Board of Directors of the Company will be held on May 28, 2015, to consider and approve the Standalone and Consolidated Audited Financial Results for the financial year ended on March 31, 2015 and for recommendation of dividend, if any. Further, in accordance with the applicable regulations of Insider Trading Regulations, the ‘Trading Window’ for dealing in equity shares of the Company shall remain closed from May 20, 2015 to May 30, 2015.
The above information is a part of company’s filings submitted to BSE.
